Itron (NASDAQ:ITRI) Receives “Buy” Rating from Roth Mkm

Roth Mkm reiterated their buy rating on shares of Itron (NASDAQ:ITRI) in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $102.00 price target on the scientific and technical instruments company’s stock.

Several other equities analysts also recently issued reports on the company. Oppenheimer upgraded Itron from a market perform rating to an outperform rating and set a $81.00 price objective for the company in a research report on Friday, January 19th. TD Cowen boosted their price objective on Itron from $107.00 to $110.00 and gave the stock an outperform rating in a research report on Wednesday, March 13th. Raymond James downgraded Itron from an outperform rating to a market perform rating in a research report on Thursday, January 4th. Canaccord Genuity Group upgraded Itron from a hold rating to a buy rating and upped their target price for the stock from $68.00 to $105.00 in a research report on Tuesday, February 27th. Finally, Robert W. Baird upped their target price on Itron from $108.00 to $115.00 and gave the stock an outperform rating in a research report on Wednesday, March 13th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of Moderate Buy and a consensus target price of $97.60.

Itron Stock Up 1.4 %

NASDAQ:ITRI opened at $95.75 on Tuesday. The company has a current ratio of 1.95, a quick ratio of 1.43 and a debt-to-equity ratio of 0.34. The stock has a 50 day moving average of $89.37 and a 200-day moving average of $75.78. The firm has a market capitalization of $4.39 billion, a PE ratio of 45.60, a price-to-earnings-growth ratio of 1.05 and a beta of 1.41. Itron has a 52 week low of $50.97 and a 52 week high of $97.84.

Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Monday, February 26th. The scientific and technical instruments company reported $1.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.75 by $0.48. The business had revenue of $577.17 million during the quarter, compared to the consensus estimate of $569.90 million. Itron had a return on equity of 12.27% and a net margin of 4.46%. The business’s revenue was up 23.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.71 earnings per share. Analysts predict that Itron will post 3.61 EPS for the current year.

Insider Activity

In other news, SVP Donald L. Reeves III sold 383 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total transaction of $28,866.71. Following the completion of the sale, the senior vice president now owns 8,708 shares in the company, valued at approximately $656,321.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Itron news, SVP Donald L. Reeves III sold 383 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $75.37, for a total transaction of $28,866.71. Following the sale, the senior vice president now directly owns 8,708 shares of the company’s stock, valued at approximately $656,321.96. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jerome J. Lande sold 14,896 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $95.25, for a total transaction of $1,418,844.00. Following the sale, the director now directly owns 5,750 shares in the company, valued at $547,687.50. The disclosure for this sale can be found here. In the last 90 days, insiders sold 30,467 shares of company stock worth $2,752,520. Insiders own 1.45% of the company’s stock.

Institutional Trading of Itron

Several large investors have recently added to or reduced their stakes in ITRI. SG Americas Securities LLC acquired a new stake in Itron during the 3rd quarter valued at $239,000. IQ EQ FUND MANAGEMENT IRELAND Ltd increased its stake in shares of Itron by 61.7% in the third quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 17,645 shares of the scientific and technical instruments company’s stock worth $1,069,000 after acquiring an additional 6,735 shares during the last quarter. Pinnacle Associates Ltd. increased its stake in shares of Itron by 25.0% in the third quarter. Pinnacle Associates Ltd. now owns 397,261 shares of the scientific and technical instruments company’s stock worth $24,066,000 after acquiring an additional 79,340 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its stake in shares of Itron by 1.2% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 19,549 shares of the scientific and technical instruments company’s stock worth $1,184,000 after acquiring an additional 236 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Itron by 453.0% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 114,856 shares of the scientific and technical instruments company’s stock worth $6,958,000 after acquiring an additional 94,085 shares during the last quarter. 96.19% of the stock is owned by institutional investors and hedge funds.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.